PMID: 16529058Mar 15, 2006Paper

Changes of drug reimbursement expenses incurred by National Health Fund in Silesian voivodeship in the period of 1999-2004

Wiadomości lekarskie : organ Polskiego Towarzystwa Lekarskiego
Piotr SwistakBarbara Błońska-Fajfrowska

Abstract

The new healthcare financing system that was implemented in 1999 finished the existence of the budgetary financing system and made the switch to insurance system. Since the very beginning of the new system expenses of drug reimbursement constituted a substantial part of healthcare services costs in all regions of Poland. Simultaneously, owing to the lack of possibility to control these costs, reimbursement expense was one of least predictable points of Sickness Funds budgets. Since 1999, in Silesian voivodeship, sales volume of reimbursed drugs increased as well as total financial burden of reimbursement. In the surveyed years an amount of money paid by insurer (sickness funds, National Health Fund) to one pack of reimbursed drug increased. Volume of consumed packs of drugs and real value of reimbursement per voivodeship citizen rose as well. In 2002 and 2003 patients' uncertainty regarding composition of new reimbursement lists promoted increase in drug sales, what in a consequence gave a substantial rise in reimbursement costs.

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.